Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins. - Test2 - elhamkhani - TriplyDB

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

http://www.wikidata.org/entity/Q33631069

about

Nanotechnology in neurology: Genesis, current status, and future prospects Checkpoints to the Brain: Directing Myeloid Cell Migration to the Central Nervous System GDNF-transfected macrophages produce potent neuroprotective effects in Parkinson's disease mouse model Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration.Agile delivery of protein therapeutics to CNS SOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature.Exploiting macrophages as targeted carrier to guide nanoparticles into glioma.Nanomaterial applications in multiple sclerosis inflamed brain.Strategies for transporting nanoparticles across the blood-brain barrier.Targeting specific cells in the brain with nanomedicines for CNS therapies Development of europium doped core-shell silica cobalt ferrite functionalized nanoparticles for magnetic resonance imaging.Progress in tumor-associated macrophage (TAM)-targeted therapeutics.Direct Macromolecular Drug Delivery to Cerebral Ischemia Area using Neutrophil-Mediated Nanoparticles.Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals.Multistage Delivery Technologies: Multifunctional, Interdisciplinary Approaches to Nanomedicine.Insights on Localized and Systemic Delivery of Redox-Based Therapeutics.Chemical Reactive Anchoring Lipids with Different Performance for Cell Surface Re-engineering Application.Recent Status of Nanomaterial Fabrication and Their Potential Applications in Neurological Disease Management

P2860

Q26771772-66988984-12F3-4360-A02E-FF8518B940DD Q28066906-0004D27F-2479-40D2-BB68-1F7DA2DFED30 Q28543023-F4618260-66B1-4D4F-B9B6-DFB4D4FA8C9B Q33978310-DB3E906A-1CD6-43B3-9274-F0357DCF8984 Q34079647-CCF061DD-BF67-49BD-9C12-3D1E6FF5BA32 Q34481558-887AABD0-0FA6-4A73-A5BA-ECB958F4A0CF Q37392913-594FB424-0A41-4F02-AFF2-AFA7366B2381 Q38330408-B6FE7BB6-CAD2-4B2B-BEB5-BCA87DDA2A1C Q38662677-979D71C0-BEA7-467A-9B56-9BCE2850EFF8 Q38674279-C7DCF297-AE98-4A82-8B5A-C9CB2816249A Q38787356-67539229-89A5-423A-A043-F0FF1937BC14 Q39267549-D8BFB832-2CA9-4967-8C8C-47983C318F4A Q41239829-0198E472-4E67-40A6-BE7C-FE6940E7C15D Q41703512-A815923F-F311-4C9A-922D-A26FD7603E02 Q41968441-B8DD5586-1D12-4870-94E8-AC1B63FB43C1 Q52720174-14099219-406B-4526-AD11-DF867456F37F Q55261866-49E455C2-0701-4770-9CA6-D0162AE914B1 Q57169956-288DAC65-E860-4A31-9E2A-6CCFA23CD24A

P2860

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

http://www.wikidata.org/entity/Q33631069

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

@ast

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

@en

type

label

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

@ast

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

@en

prefLabel

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

@ast

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

@en

P1433

Q33631069-B7221801-A4CE-4477-9236-86A245BCBCE0

P1476

Q33631069-C768D1E0-95C0-405E-A15B-0F4E14CB0940

P2093

Q33631069-1A9ED260-55C1-49F9-8C55-E7AA7542311D

Q33631069-42910F7D-D19B-4A5E-8A38-C48569EA6D36

Q33631069-6B3DEC6A-2705-4FE9-91A8-DC0D5822B375

Q33631069-8362937D-128C-4C90-8FD1-4442F95620E2

Q33631069-B2E1B807-61F3-4115-BBA1-4731E40689E5

Q33631069-C135B567-D2E9-4580-A98F-37033F0A7FD9

Q33631069-C503802F-02A3-4957-B169-5DF5BEC37106

Q33631069-D66F74F1-CFD6-452B-9E71-E1D3B6421753

Q33631069-ECF9CA53-DAF8-488A-BA9D-9758C8D485D0

Q33631069-FA5090D3-7234-44CE-93B9-423151E40857

P2860

Q33631069-058C284B-32E5-4E47-AFE0-84879CC75B26

Q33631069-09F5F3BF-8DD2-4F30-B158-C803FB5F8C90

Q33631069-1101A620-7A42-46D7-999E-0FC33937158E

Q33631069-12B109C8-6E14-4283-9565-6FFB837D9A25

Q33631069-1339C3FE-1E64-4273-ABFF-022E3463F724

Q33631069-14749C98-2FC7-4435-A160-C94CA0B24FBD

Q33631069-182E5AFD-99EC-4B9C-A429-B6089C476A8B

Q33631069-215191B5-3CB0-4427-883B-3CE572C6F5B8

Q33631069-23ABCF1B-0E28-4357-A01D-EBD9E698525A

Q33631069-23CFD444-E25C-4B4E-B36D-FFC42BB643A1

P304

Q33631069-5A33367A-691B-4C0F-9C39-71DE0D5BCF3C

P31

Q33631069-DD15E446-3BF5-44C8-9688-77A2A070BF0F

P356

Q33631069-38ED54B3-77BF-4F2D-BAD6-9289860E6B86

P433

Q33631069-1E980211-070A-4E25-B30B-C784A4EFFE4D

P478

Q33631069-2D9E5ACF-1C05-4468-A6F1-1568763767B5

P50

Q33631069-0A57296F-BD05-4ABA-A16F-C8010AAF1552

P577

Q33631069-928A1FC6-D4EC-4A16-8343-ED71B54DAE10

P5875

Q33631069-D9DFE827-E380-42C2-ACDC-66766117EC08

P698

Q33631069-84C40752-47DA-4774-A2FA-7E8F267ABD60

P932

Q33631069-EFAAC9C3-F33A-4BB8-B618-4A7219B547E1

P356

P1433

P1476

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins

@en

P2093

Devika S Manickam

http://www.w3.org/2001/XMLSchema#string

Elena V Batrakova

http://www.w3.org/2001/XMLSchema#string

Howard E Gendelman

http://www.w3.org/2001/XMLSchema#string

Matthew J Haney

http://www.w3.org/2001/XMLSchema#string

Natalia L Klyachko

http://www.w3.org/2001/XMLSchema#string

Poornima Suresh

http://www.w3.org/2001/XMLSchema#string

R Lee Mosley

http://www.w3.org/2001/XMLSchema#string

Shawn D Hingtgen

http://www.w3.org/2001/XMLSchema#string

Vivek Mahajan

http://www.w3.org/2001/XMLSchema#string

Yuling Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases

Nanocarriers for vascular delivery of antioxidants

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

The blood-brain barrier in health and chronic neurodegenerative disorders

Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.

NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.

Interleukin-1beta -induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study.

Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease

Protein diffusion in living skeletal muscle fibers: dependence on protein size, fiber type, and contraction.

P304

1403-1422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM.13.115

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258633038

http://www.w3.org/2001/XMLSchema#string

P698

24237263

http://www.w3.org/2001/XMLSchema#string

P932

4025996

http://www.w3.org/2001/XMLSchema#string